Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
Top Cited Papers
- 21 June 2009
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 61 (6), 428-437
- https://doi.org/10.1016/j.addr.2009.03.009
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle BiodistributionMolecular Pharmaceutics, 2008
- Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potentialBiomaterials, 2007
- Nucleation of protein fibrillation by nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007
- Nanoparticles as catalysts for protein fibrillationProceedings of the National Academy of Sciences of the United States of America, 2007
- Probing the interactions of proteins and nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007
- An investigation on the role of plasma and serum opsonins on the evternalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife Sciences, 1995
- The use of microdialysis for the determination of plasma protein binding of drugsJournal of Pharmaceutical and Biomedical Analysis, 1992
- The role of complement in inflammation and phagocytosisImmunology Today, 1991
- The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908Life Sciences, 1987